Chinese scientists make breakthroughs in the development of third-generation uterine cervix cancer vaccine



[ad_1]

BEIJING, Dec. 28 (Xinhua) – Xia Xiaoping Group of Xiamen University, in southeastern China, has blanketed 20 types of human papillomavirus from seven types of viral particles, laying the groundwork for 39, a technology essential for the development of the third generation of cancer vaccine cervix uteri.

Cervical cancer comes in the form of a human papilloma virus. Current vaccines use viral particles similar to natural viral particles: they can protect 90% of cervical cancer cases, but about 10% of cervical cancers are not yet preventable. Third of the cervical cancer resistant vaccine in the traditional method, will face problems in large dose and response and other fat.

Chia Zhao Ning's team compared HPP particle structures, in which some viruses had a similar structure: a viral particle composed of three types of viruses was designed. She has covered 20 types of HPV with seven viral particles and developed third-generation Vaccine against cervical cancer.

[ad_2]
Source link